(Best Practices LLC: Chapel Hill, North Carolina) -- The research findings in a recent report from Best Practices LLC are the culmination of extensive benchmark surveys and executive interviews. Initial surveys were conducted with executives at leading pharmaceutical companies. Analysts at Best Practices then performed in-depth interviews with 15 executives at nine leading pharmaceutical companies.

Specifically, the study examines the following areas:
•   Integrating communication needs into the design of a clinical study
•   Choosing winning tactics for communicating study findings to physicians, managed care organizations, investors, and consumers
•   Avoiding the “class effect” in which study results favorably affect other brands
•   Leveraging study results to positively affect other indications for the same brand

The report is designed to help pharmaceutical manufacturers better develop and execute strategies for communicating clinical trial results.

 …